The Vistria Group and Excellere Partners Acquire SCA Pharmaceuticals

The Vistria Group Acquires BioCare, Inc.

November 8, 2021

Healthcare Services

The Vistria Group has acquired BioCare, Inc., a Tempe-based specialty pharmaceutical distributor, specialty pharmacy and pharmaceutical logistics provider. The deal is Vistria’s first investment from its $2.68 billion Fund IV and aims to support BioCare’s growth — both organically and via acquisitions — to expand access to therapies for rare and orphan diseases.

Vistria Group Acquires Mission Healthcare from HCAP Partners

December 16, 2020

Healthcare Services

Chicago-based private investment firm Vistria Group has acquired Mission Healthcare, a San Diego-based home health and hospice provider, in a transaction that represents an exit for HCAP Partners. Vistria’s investment will support Mission Healthcare’s continued growth across Southern California and other markets; terms were not disclosed.

The Vistria Group, Nautic Partners and General Atlantic Acquire PANTHERx Rare

July 26, 2022

Healthcare Services

An investor consortium led by The Vistria Group, with Nautic Partners and General Atlantic, completed the acquisition of PANTHERx Rare, a Pittsburgh-based specialty pharmacy focused on rare and orphan diseases, closing on July 14, 2022. Following the close, Vistria Senior Operating Partner Nick Loporcaro was appointed Chairman of PANTHERx's board; the deal expands the buyers' capabilities in pharma services and rare-disease specialty pharmacy.

GHO Capital and The Vistria Group Acquire Alcami Corporation

January 3, 2023

Healthcare Services

GHO Capital Partners and The Vistria Group have acquired a 50/50 controlling interest in Alcami Corporation from funds affiliated with Madison Dearborn Partners and Ampersand Capital Partners. Alcami is a US-based contract development and manufacturing organization (CDMO) with capabilities in sterile fill-finish, formulation and analytical lab services, and cGMP biostorage; Ampersand and Alcami management reinvested significant equity as part of the transaction.

Enhanced Healthcare Partners & Bourne Partners Strategic Capital Acquire Pharmaceutical Associates, Inc.

November 6, 2019

Pharmaceuticals

Enhanced Healthcare Partners (EHP), together with Bourne Partners Strategic Capital (BPSC), announced the acquisition of Pharmaceutical Associates, Inc. (PAI), a U.S. manufacturer of generic liquid and unit-dose pharmaceuticals. The investment will provide growth capital to expand PAI's manufacturing capacity, product lines and market footprint while leveraging BPSC's pharmaceutical network and EHP's healthcare investment experience.

Pharos Capital Acquires Vantage Outsourcing to Build Ophthalmology Services Platform

September 22, 2021

Healthcare Services

Pharos Capital Group has acquired Vantage Outsourcing, a cataract surgical support services provider headquartered in Effingham, Illinois. Pharos will partner with industry executive Bradley Hill and work with Vantage's existing leadership—co-founder and CEO Ann Deters and President Chris Swing (who retain minority stakes)—to build a broader surgical support services platform across ophthalmology and other specialties.